Index by author

September 01, 2023; Volume 90,Issue 9

  1. Modesto-lowe, Vania

    1. A practical guide for buprenorphine initiation in the primary care setting
      Roberto León-Barriera, MD, Samantha Jayne Zwiebel, MD, MA and Vania Modesto-Lowe, MD, MPH
      Cleveland Clinic Journal of Medicine September 2023, 90 (9) 557-564; DOI: https://doi.org/10.3949/ccjm.90a.23022

      The authors review changes in prescribing laws and outline buprenorphine induction protocols that can be adopted in the primary care setting.

  2. Pantalone, Kevin M.

    1. Should I consider metformin therapy for weight loss in patients with obesity but without diabetes?
      Paloma Rodriguez, MD, Kevin M. Pantalone, DO, ECNU, FACE, Marcio L. Griebeler, MD and Bartolome Burguera, MD, PhD
      Cleveland Clinic Journal of Medicine September 2023, 90 (9) 545-548; DOI: https://doi.org/10.3949/ccjm.90a.22096

      The authors appraise the evidence to date for weight loss with metformin in this patient population.

  3. Persits, Ian

    1. When should pharmacologic therapies be used for uremic pericarditis?
      When should pharmacologic therapies be used for uremic pericarditis?
      Osamah Badwan, MD, Warren Skoza, MD, Lorenzo Braghieri, MD, Ian Persits, DO and Allan L. Klein, MD, FRCP (C), FACC, FAHA, FASE, FESC
      Cleveland Clinic Journal of Medicine September 2023, 90 (9) 549-554; DOI: https://doi.org/10.3949/ccjm.90a.23003

      If symptoms return or fail to improve with renal replacement therapy, drug therapy may be considered.

  4. Plante, Marie

    1. If a patient has cirrhosis, should I correct coagulation abnormalities before a minor invasive procedure?
      Emily B. Wolf, MD, Marie Plante, MD and Razvan M. Chirila, MD
      Cleveland Clinic Journal of Medicine September 2023, 90 (9) 541-543; DOI: https://doi.org/10.3949/ccjm.90a.23005

      Hemostatic abnormalities in cirrhosis can include thrombocytopenia, prolonged prothrombin time, prolonged activated partial thromboplastin time, elevated international normalized ratio, and decreased fibrinogen.

  5. Rodriguez, Paloma

    1. Should I consider metformin therapy for weight loss in patients with obesity but without diabetes?
      Paloma Rodriguez, MD, Kevin M. Pantalone, DO, ECNU, FACE, Marcio L. Griebeler, MD and Bartolome Burguera, MD, PhD
      Cleveland Clinic Journal of Medicine September 2023, 90 (9) 545-548; DOI: https://doi.org/10.3949/ccjm.90a.22096

      The authors appraise the evidence to date for weight loss with metformin in this patient population.

  6. Skoza, Warren

    1. When should pharmacologic therapies be used for uremic pericarditis?
      When should pharmacologic therapies be used for uremic pericarditis?
      Osamah Badwan, MD, Warren Skoza, MD, Lorenzo Braghieri, MD, Ian Persits, DO and Allan L. Klein, MD, FRCP (C), FACC, FAHA, FASE, FESC
      Cleveland Clinic Journal of Medicine September 2023, 90 (9) 549-554; DOI: https://doi.org/10.3949/ccjm.90a.23003

      If symptoms return or fail to improve with renal replacement therapy, drug therapy may be considered.

  7. Wang, Wen-ju

    1. Cutaneous metastasis from gastric carcinoma
      Li-wen Zhang, MD, Wen-ju Wang, MD, Tao Chen, MD, PhD and Rong-hua Xu, MD
      Cleveland Clinic Journal of Medicine September 2023, 90 (9) 533-534; DOI: https://doi.org/10.3949/ccjm.90a.22085

      The patient presented with asymptomatic nodules and alopecia of the scalp 3 years after treatment for gastric adenocarcinoma.

  8. Wolf, Emily B.

    1. If a patient has cirrhosis, should I correct coagulation abnormalities before a minor invasive procedure?
      Emily B. Wolf, MD, Marie Plante, MD and Razvan M. Chirila, MD
      Cleveland Clinic Journal of Medicine September 2023, 90 (9) 541-543; DOI: https://doi.org/10.3949/ccjm.90a.23005

      Hemostatic abnormalities in cirrhosis can include thrombocytopenia, prolonged prothrombin time, prolonged activated partial thromboplastin time, elevated international normalized ratio, and decreased fibrinogen.

  9. Xu, Rong-hua

    1. Cutaneous metastasis from gastric carcinoma
      Li-wen Zhang, MD, Wen-ju Wang, MD, Tao Chen, MD, PhD and Rong-hua Xu, MD
      Cleveland Clinic Journal of Medicine September 2023, 90 (9) 533-534; DOI: https://doi.org/10.3949/ccjm.90a.22085

      The patient presented with asymptomatic nodules and alopecia of the scalp 3 years after treatment for gastric adenocarcinoma.

  10. Zhang, Li-wen

    1. Cutaneous metastasis from gastric carcinoma
      Li-wen Zhang, MD, Wen-ju Wang, MD, Tao Chen, MD, PhD and Rong-hua Xu, MD
      Cleveland Clinic Journal of Medicine September 2023, 90 (9) 533-534; DOI: https://doi.org/10.3949/ccjm.90a.22085

      The patient presented with asymptomatic nodules and alopecia of the scalp 3 years after treatment for gastric adenocarcinoma.

« Previous (Pages : 1 2 3 4 ... 4) Next »
Back to top

In this issue